8.30 Kempton – Straightforward if you trust the numbers🏇⤵️👇

·


This is a typical Kempton 6f handicap where the temptation is to overcomplicate things. Don’t.
The Comment Shaper tells you this will be steadily run — no confirmed front runner, very little early pressure, and a low chance of a pace collapse. That usually favours those sitting handy, but it also turns the race tactical rather than truly run.
Now bring in the key angle: HRB TimeWise Master ratings.
State Of Madness – clear Rank 1
Em Four – solid Rank 2
The rest are already against it historically
That matters. Rank 1 dominates these races long term, and ignoring it usually costs.
The principals
State Of Madness is the one everything revolves around. He’s consistent, in form, and crucially not a one-dimensional hold-up horse despite what the raw style suggests. He’s been ridden in a variety of ways and still finishes his races strongly. The stable switch adds a bit of upside and a 2lb rise looks manageable. If he sits anywhere near midfield, he’s the most likely winner.
Em Four is the obvious danger. He won over C&D two weeks ago and is far more likely to be on the speed, which is a positive given the race shape. The concern is whether that was his ceiling — he’s up 3lb and now faces a deeper, more competitive field.
Brazen Idol ran well behind Em Four on his return and has scope to improve again, but he’s a Rank 3 horse in a race that doesn’t suit closers. That’s a poor combination.
True Promise will have support with Oisin Murphy booked and a good draw, but he’s become a professional placer. From a Rank 4 position, he looks more likely to hit the frame again than win.
The call
You can make a case that the race setup favours Em Four. That’s fair. But over time, these races are won by the top-rated horses — and State Of Madness has a clear edge there.
If he’s ridden with any intent tactically, he wins.
Selection: STATE OF MADNESS
Saver: Em Four
Verdict: Medium confidence

Leave a comment

Get updates

From art exploration to the latest archeological findings, all here in our weekly newsletter.

Subscribe